Crossing the "only one analyte" barrierOur "Total Stem-Loop (TSL)" approach may enable us to cross the "only one analyte" barrier and finally unleash the full clinical utility of liquid biopsy in cancer patients.
Contact:Dr. S.T. Tan, CEOEmail: sttan@life.nthu.edu.tw
張小姐,業務Tel: 03-5610507 (週一~週五 15:00-18:00)Phone: 0966-676088, Email: nanobio.as@gmail.comhttp://www.nbdinc.com.tw/hot_432133.htmlCrossing the "only one analyte" barrier2022-05-282023-05-28
